Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930413-12-005739
Filing Date
2012-10-15
Accepted
2012-10-15 17:00:37
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 c71079_10ka.htm 10-K/A 30255
  Complete submission text file 0000930413-12-005739.txt   5430147

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE ibio-20120630.xml EX-101.INS 1111135
3 XBRL SCHEMA FILE ibio-20120630.xsd EX-101.SCH 66472
4 XBRL CALCULATION FILE ibio-20120630_cal.xml EX-101.CAL 33117
5 XBRL DEFINITION FILE ibio-20120630_def.xml EX-101.DEF 289545
6 XBRL LABEL FILE ibio-20120630_lab.xml EX-101.LAB 400695
7 XBRL PRESENTATION FILE ibio-20120630_pre.xml EX-101.PRE 295336
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-35023 | Film No.: 121144322
SIC: 2834 Pharmaceutical Preparations